文献速递头颈部肿瘤放疗

头颈癌放疗中复杂口腔治疗装置使用相关因素

Factors associated with complex oral treatment device usage in patients with head and neck cancer.
PubMed 文献 · Clin Transl Radiat Oncol · 2021-08-08

该回顾性研究基于1992至2013年SEER-Medicare数据库,分析4511例接受调强放疗的头颈癌患者复杂口腔治疗装置(COTD)使用情况。结果显示57.2%患者使用COTD,使用率从1992年36.36%升至2013年67.44%,但高龄、男性、非西班牙裔黑人和路易斯安那州居民使用可能性较低。

要点

  • 头颈癌IMRT患者COTD使用率从1992年36.36%增至2013年67.44%。
  • 86岁及以上、男性、非西班牙裔黑人及路易斯安那州居民COTD使用可能性较低。
  • 肿瘤部位、分级、分期或IMRT功能与COTD使用无显著关联。

核心结论

  • 尽管COTD使用率随时间增加,但年龄、性别和地理差异与COTD使用相关。

研究设计与样本

  • 回顾性分析1992至2013年SEER-Medicare数据库中接受IMRT的舌、口底、鼻咽、扁桃体或口咽癌患者,共4511例符合标准。

主要发现

  • 4511例患者中2579例(57.2%)符合COTD使用标准,1932例(42.8%)未使用。
  • COTD使用率从1992年36.36%上升至2013年67.44%(p < .0001)。
  • 86岁及以上较66-70岁患者使用COTD可能性更低(OR = 0.713,95% CI: 0.528-0.962)。
  • 男性较女性使用COTD可能性更低(OR = 0.817,95% CI: 0.710-0.941)。
  • 非西班牙裔黑人较非西班牙裔白人使用COTD可能性更低(OR = 0.750,95% CI: 0.582-0.966);路易斯安那州居民OR = 0.367(95% CI: 0.279-0.483)。

临床怎么用

  • 关注高龄、男性、非西班牙裔黑人及特定地区头颈癌放疗患者COTD使用不足,针对性提高可及性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The objective was to identify clinical and epidemiological factors associated with utilization of a complex oral treatment device (COTD), which may decrease toxicity in patients undergoing radiation therapy for head and neck cancer (HNC). MATERIALS AND METHODS: We retrospectively reviewed data from 1992 to 2013 in the Surveillance, Epidemiology, and End Results (SEER)-Medicare databases to analyze COTD usage during intensity-modulated radiation therapy (IMRT) for patients diagnosed with cancer of the tongue, floor of mouth, nasopharynx, tonsil, or oropharynx. Patients with a radiation simulation and complex treatment device code within 4 weeks before the first IMRT claim were identified as meeting COTD usage criteria. Demographic, regional, tumor, and treatment data were analyzed. RESULTS: Out of 4511 patients who met eligibility criteria, 1932 patients (42.8%) did not utilize a COTD while 2579 (57.2%) met usage criteria. COTD utilization increased over time (36.36% usage in 1992 vs. 67.44% usage in 2013, p < .0001). Patients less likely to receive a COTD included those aged 86 years or older compared to those aged 66-70 (OR = 0.713, 95% CI: 0.528-0.962), male patients (OR = 0.817, 95% CI: 0.710-0.941), non-Hispanic Black patients compared to non-Hispanic White patients (OR = 0.750, 95% CI: 0.582-0.966), and Louisiana residents (OR = 0.367, 95% CI: 0.279-0.483). Cancer site, grade, stage, or function of IMRT had no significant association with COTD usage. CONCLUSIONS: This study serves as the first known SEER-Medicare review of COTD utilization. Despite an increase in COTD usage over time, our results indicate age, gender, and geographic disparities are associated with utilization. Further research and development into methods that increase availability of COTDs may help increase utilization in specific patient populations.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Palasi S, Zhang N, Bankston M, et al. Factors associated with complex oral treatment device usage in patients with head and neck cancer. Clin Transl Radiat Oncol. 2021. PMID: 34430717. doi:10.1016/j.ctro.2021.08.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。